FIELD: chemical-pharmaceutical industry.
SUBSTANCE: group of inventions relates to the chemical and pharmaceutical industry and is a group of tools that enhance the effect of rehabilitation after nerve damage, enhancing the restoration of a functional impairment for a patient with nerve damage and enhancing the relief of a functional impairment for a patient with nerve damage for rehabilitation, which contain 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or salt thereof. These agents are used in combination with rehabilitation after nerve damage.
EFFECT: group of inventions provides a synergistic result of the joint use of an agent containing 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol and rehabilitation after nerve damage.
3 cl, 7 dwg, 2 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| IN VIVO METHOD FOR DETERMINING BIOCOMPATIBILITY OF SCAFFOLDS FOR NEUROTRANSPLANTATION | 2021 |
|
RU2812608C2 |
| MEDICINAL AGENT OFFERING ANTI-ISCHEMIC, ANTIHYPOXIC AND ANTICONVULSANT EFFECT IN CRANIAL TRAUMA | 2005 |
|
RU2309745C2 |
| UROKINASE INHIBITORS ADMINISTRATION FOR TREATMENT AND/OR PREVENTION OF NEUROPATHOLOGICAL DISEASES | 2006 |
|
RU2410087C2 |
| MEANS FOR THERAPY OF TOXIC ENCEPHALOPATHY CAUSED BY CARBON MONOXIDE | 2015 |
|
RU2669779C2 |
| MEDICINAL AGENT SHOWING MULTIFACTOR NEUROPROTECTIVE AND NOOTROPIC EFFECT IN CRANIAL TRAUMA | 2005 |
|
RU2318501C2 |
| ANTICONVULSANT AND ANTIHYPOXIC AGENT | 2008 |
|
RU2393857C2 |
| METHOD FOR MODELING THE DEVELOPMENT OF BRAIN HEMORRHAGE IN HYPERTENSIVE MICE | 2017 |
|
RU2678798C1 |
| COMPOSITIONS AND METHODS FOR TREATING NON-ACUTE PERIODS FOLLOWING NEUROLOGICAL DAMAGE | 2009 |
|
RU2501564C2 |
| MEDICATION PRODUCING ANTI-ISCHEMIC, ANTIHYPOXIC AND ANTIAMNESTIC ACTION IN ACUTE PERIODE OF CRANIOCEREBRAL TRAUMA | 2009 |
|
RU2424802C2 |
| TETRAPEPTIDE STIMULATING FUNCTIONAL ACTIVITY OF NEURONS, PHARMACOLOGICAL AGENT BASED ON THEREOF AND METHOD OF ITS USE | 1999 |
|
RU2155063C1 |
